Wikipedia -WSS

Wikipedia

author：entertainment 2025-09-29 18:59:36 - browse：4348

Cell and gene therapy sign seen at a conference. -- biotech coverage from STAT — Jonathan Wosen for STAT

CARLSBAD, Calif. — Biotech CEOs leading cell and gene therapy companies spoke frankly at a conference here last week about the tough choices they’re making to preserve limited cash amid the industry’s ongoing slowdown.

The company leaders said that they’ve felt added pressure to use smaller teams to work quickly on fewer projects, and at times to partner with outside firms that have specific manufacturing and research expertise. Not all of these changes are bad, they added, noting that efficiency is a good trait for a biotech company in any market.

The candid conversation on Thursday was part of Meeting on the Mesa, an annual cell and gene therapy conference held in Carlsbad, in the north of San Diego County. And it provided a glimpse into discussions happening across the life science industry as biotech markets continue a sharp slump that dates back to late 2021.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Group opposing PBM reform sets lobbying record

WSS

A public scorecard can help hold safety

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

At Orexo, a ‘turning point’ for everything but digital health

What we know about the American soldier detained in North Korea

FDA seeking to stop procedures at two unregulated stem cell clinics

leisure time

Wikipedia

leisure time

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

FDA seeking to stop procedures at two unregulated stem cell clinics

Novavax promises a turnaround & Lilly roils the obesity market

Lack of darker skin in textbooks, journals harms patients of color

Jerome Adams on the need for new antivirals for Covid

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

Alkermes shareholders re

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

What does generative AI mean for health care? We asked experts

Group opposing PBM reform sets lobbying record

focus

Startup Neumora takes a novel depression drug to Phase 3

BridgeBio heart drug succeeds in pivotal study

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

Sanders adds drug shortage policies to pandemic preparedness bill

Biden administration sends mixed signals on US soldier who crossed into North Korea

Google and Epic fight stronger regulation of AI in health care

hotspot

hotspot

Wikipedia

focus